But the next worrying option could be a progeny or something like an immuno-avoidant strain that has never been needed, she said.
Examining previous variables can give an idea of what worked – or didn’t work – to keep them. The new Gamma study provides further evidence for this international travel ban, at least as introduced by the United States, is unlikely to prevent the global spread of the option.
The range was first recognized in Brazil in late 2020. In May of that year, the United States banned most non-US citizens from traveling in the country from Brazil, a restriction that remains in effect until November 2021. However, the range was opened in the United States in January 2021 and soon spread to dozens of countries.
Because Gamma has never dominated the world, its study of distribution provides a “clearer” picture of the effectiveness of the travel ban, said Titiana Vasileva, a molecular epidemiologist at the University of California, San Diego and author of the study. “When it comes to studying variables like delta – something that causes mass outbreaks everywhere – it’s sometimes really hard to find patterns because it’s happening on a very large scale and very quickly,” she said.
Dr Faufer said that with the ongoing global emergency, with a rapidly changing virus, there is an understandable reason to focus on the future. As the world’s attention shifted to Delta and then to Omicron, he and his colleagues discussed whether to continue studying Mu’s old news.
Dr. remembers. “But we believe that there is still room for high-quality research that asks questions about existing variables that are worrying and tries to rethink what happened.
Add Comment